Poor lipid control in Type-2 diabetics with and without ischemic heart disease

Endocrine

Volumn 21, Issue 3, 2003, Pages 217-220

  Akbar, Daad H ^a,b   Al Gamdi, Aish A ^a   Hejazi, Nariman A ^a  

^a KING ABDUL AZIZ UNIVERSITY HOSPITAL   (Saudi Arabia)

^b NONE   (Saudi Arabia)

Author keywords

Control; Dyslipidemia; Type 2 diabetics

Indexed keywords

HIGH DENSITY LIPOPROTEIN; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BLOOD GLUCOSE MONITORING; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORRELATION ANALYSIS; DIET RESTRICTION; DISEASE ASSOCIATION; FAMILY HISTORY; FEMALE; FOLLOW UP; FREQUENCY ANALYSIS; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; ISCHEMIC HEART DISEASE; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; SEX RATIO; STATISTICAL SIGNIFICANCE;

EID: 0141859927     PISSN: 1355008X     EISSN: 15590100     Source Type: Journal    
DOI: 10.1385/ENDO:21:3:217     Document Type: Article

References (31)

1. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. (2001). JAMA 285, 2486-2497.
2. Malmberg, K., Yusuf, S., Gerstein, H., et al. (2000). Circulation 102, 1014-1019.
3. O'Keefe, J., Miles, J., Harris, W., et al. (1999). Mayo Clin. Proc. 74, 171-180.
4. Turner, R. C., Millns, H., Neil, H. A., et al. (1998). Br. Med. J. 316, 823-828.
5. Anonymous. (2002). Diabetes Care 25(Suppl. 1), S74-S77.
6. Mokdad, A. H., Ford, E. S., Bowman, B. A., et al. (2000). Diabetes Care 23, 1278-1283.
7. American Diabetes Association. (2001). Diabetes Care 23, S4-S19.
8. Cavaghan, M. K., Ehrmann, D. A., and Polonsky, K. S. (2000). J. Clin. Invest. 106, 329-333.
9. Polonsky, K. S., Sturis, J., and Bell, G. I. (1996). N. Engl. J. Med. 334, 777-783.
10. Siegel, R. D., Cupples, A., Schaefer, E. J., and Wilson, P. W. (1996). Metabolism 45(10), 1267-1272.
11. Miller, M. (1998). Eur. Heart J. 19, H18-H22.
12. Miller, M. (1999). Clin. Cardiol. 22, II1-II6.
13. Saaddine, J. B., Engelgau, M. M., Beckles, G. L., Gregg, E. W., Thompson, T. J., and Narayan, K. M. V. (2002). Ann. Intern. Med. 136, 565-574.
14. George, P. B., Kenneth, J., Tobin, D. O., et al. (2001). Am. Heart J. 142(5), 857-863.
15. Beckles, G. L., Engelgau, M. M., Narayan, K. M., Herman, W. H., Aubert, R. E., and Williamson, D. F. (1998). Diabetes Care 21, 1432-1438.
16. Harris, M. I. (2000). Diabetes Care 6, 754-758.
17. The Scientific Committee Assurance in Primary Health Care Manual. (1994). WHO-EM/PHC/81-A/G/93.
18. Khattab, M., Abolfotouh, M., Alakija, W., Humaidi, M., Al Tokhy, M., and Al Khaldi, Y. (1996). Diabetes Res. 31, 243-254.
19. Al Owayyed, A., Al Shaikh, A., and Taha, S. (1997). Saudi Med. J. 18, 175-179.
20. Al Khalidi, Y. and Khan, M. (2002). Saudi Med. J. 23, 51-55.
21. Barrett-Connor, E. and Wingard, D. L. (1983). Am. J. Epidemiol. 118(4), 489-496.
22. Goldberg, R. B., Mellies, M. J., Sacks, F. M., et al. (1998). Circulation 98, 2513-2519.
23. Pyorala, K., Pedersen, T. R., Kjekshus, J., Faergeman, O., Olsson, A. G., and Thorgeirsson, G. (1997). Diabetes Care 20, 614-620.
24. The Long Intervention with Pravastatin in Ischemic Heart Disease (LIPID) Study Group. (1998). N. Engl. J. Med. 339, 1349-1357.
25. Sacks, F. M., Pfeffer, M. A., Loye, L. A., et al. (1996). N. Engl. J. Med. 335, 1001-1009.
26. Downs, J. R., Cleafield, P. A., Langendorfer, A., Stein, E. A., Kruyer, W., and Gotto, A. M. Jr. (1998). JAMA 279, 1615-1622.
27. Frick, M. H., Elo, O., Haapa, K., et al. (1987). N. Engl. J. Med. 317, 1237-1245.
28. Rubins, H. B., Robins, S. J., Collins, D., et al. (1999). N. Engl. J. Med. 341, 410-418.
29. Wooldridge, K. L., Wallston, K. A., Graber, A. L., et al. (1992). Diabetes Educator 18, 495-500.
30. Diabetes Mellitus Working Group. (1997). Veterans Health Administration Clinical Guidelines for Management of Diabetes Mellitus. Version 4.0. Washington, DC: Veterans Health Administration.
31. Anderson, R. M. and Funnel, M. M. (2000). Diabetes Educator 26, 597-604.